Literature DB >> 25565498

Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study.

Samantha A Molsberry1, Fabrizio Lecci, Lawrence Kingsley, Brian Junker, Sandra Reynolds, Karl Goodkin, Andrew J Levine, Eileen Martin, Eric N Miller, Cynthia A Munro, Ann Ragin, Ned Sacktor, James T Becker.   

Abstract

OBJECTIVE: The longitudinal trajectories that individuals may take from a state of normal cognition to HIV-associated dementia are unknown. We applied a novel statistical methodology to identify trajectories to cognitive impairment, and factors that affected the 'closeness' of an individual to one of the canonical trajectories.
DESIGN: The Multicenter AIDS Cohort Study (MACS) is a four-site longitudinal study of the natural and treated history of HIV disease among gay and bisexual men.
METHODS: Using data from 3892 men (both HIV-infected and HIV-uninfected) enrolled in the neuropsychology substudy of the MACS, a Mixed Membership Trajectory Model (MMTM) was applied to capture the pathways from normal cognitive function to mild impairment to severe impairment. MMTMs allow the data to identify canonical pathways and to model the effects of risk factors on an individual's 'closeness' to these trajectories.
RESULTS: First, we identified three distinct trajectories to cognitive impairment: 'normal aging' (low probability of mild impairment until age 60); 'premature aging' (mild impairment starting at age 45-50); and 'unhealthy' (mild impairment in 20s and 30s) profiles. Second, clinically defined AIDS, and not simply HIV disease, was associated with closeness to the premature aging trajectory, and, third, hepatitis-C infection, depression, race, recruitment cohort and confounding conditions all affected individual's closeness to these trajectories.
CONCLUSION: These results provide new insight into the natural history of cognitive dysfunction in HIV disease and provide evidence for a potential difference in the pathophysiology of the development of cognitive impairment based on trajectories to impairment.

Entities:  

Mesh:

Year:  2015        PMID: 25565498      PMCID: PMC4743499          DOI: 10.1097/QAD.0000000000000561

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

Authors:  E N Miller; P Satz; B Visscher
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

2.  DESCRIBING DISABILITY THROUGH INDIVIDUAL-LEVEL MIXTURE MODELS FOR MULTIVARIATE BINARY DATA.

Authors:  Elena A Erosheva; Stephen E Fienberg; Cyrille Joutard
Journal:  Ann Appl Stat       Date:  2007       Impact factor: 2.083

3.  Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.

Authors:  Pornpun Vivithanaporn; Krista Nelles; Leah DeBlock; Stephen C Newman; M John Gill; Christopher Power
Journal:  J Neurol Sci       Date:  2011-09-17       Impact factor: 3.181

4.  A comparison of the effects of long-term alcohol abuse and aging on the performance of verbal and nonverbal divided attention tasks.

Authors:  J T Becker; N Butters; A Hermann; N D'Angelo
Journal:  Alcohol Clin Exp Res       Date:  1983       Impact factor: 3.455

5.  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

Authors:  Diana De Ronchi; Irma Faranca; Domenico Berardi; Paolo Scudellari; Marco Borderi; Roberto Manfredi; Laura Fratiglioni
Journal:  Arch Neurol       Date:  2002-05

6.  Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models.

Authors:  Fabrizio Lecci; Brian Junker; Lewis H Kuller; Oscar L Lopez; James T Becker
Journal:  Am J Epidemiol       Date:  2015-07-23       Impact factor: 4.897

7.  Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.

Authors:  James T Becker; Lawrence A Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; Ola A Selnes
Journal:  Int J Epidemiol       Date:  2014-04-24       Impact factor: 7.196

8.  Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study.

Authors:  L A Kingsley; R Detels; R Kaslow; B F Polk; C R Rinaldo; J Chmiel; K Detre; S F Kelsey; N Odaka; D Ostrow
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

10.  Evaluation of dementia in the cardiovascular health cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

View more
  14 in total

1.  Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.

Authors:  Hamza Coban; Kevin Robertson; Marlene Smurzynski; Supriya Krishnan; Kunling Wu; Ronald J Bosch; Ann C Collier; Ronald J Ellis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

Review 2.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

3.  Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine.

Authors:  Shibani Mukerji; Roxanna Haghighat; Vikas Misra; David R Lorenz; Alex Holman; Anupriya Dutta; Dana Gabuzda
Journal:  AIDS Behav       Date:  2017-07

Review 4.  Neurologic Complications of Human Immunodeficiency Virus Infection.

Authors:  Deanna Saylor
Journal:  Continuum (Minneap Minn)       Date:  2018-10

5.  Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.

Authors:  Samantha A Molsberry; Yu Cheng; Lawrence Kingsley; Lisa Jacobson; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; James T Becker
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

6.  Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?

Authors:  David P Sheppard; Steven Paul Woods; Mark W Bondi; Paul E Gilbert; Paul J Massman; Katie L Doyle
Journal:  Clin Neuropsychol       Date:  2015-08-26       Impact factor: 3.535

7.  Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Authors:  Mikhail Popov; Samantha A Molsberry; Fabrizio Lecci; Brian Junker; Lawrence A Kingsley; Andrew Levine; Eileen Martin; Eric Miller; Cynthia A Munro; Ann Ragin; Eric Seaberg; Ned Sacktor; James T Becker
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

8.  Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.

Authors:  Natalia L Oliveira; Edward H Kennedy; Ryan Tibshirani; Andrew Levine; Eileen Martin; Cynthia Munro; Ann B Ragin; Leah H Rubin; Ned Sacktor; Eric C Seaberg; Andrea Weinstein; James T Becker
Journal:  AIDS       Date:  2021-05-01       Impact factor: 4.177

Review 9.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

10.  Predictors of transitions in frailty severity and mortality among people aging with HIV.

Authors:  Thomas D Brothers; Susan Kirkland; Olga Theou; Stefano Zona; Andrea Malagoli; Lindsay M K Wallace; Chiara Stentarelli; Cristina Mussini; Julian Falutz; Giovanni Guaraldi; Kenneth Rockwood
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.